PT  - JOURNAL ARTICLE
AU  - Bukhari, Muhammad Tayyeb
TI  - Efficacy of lightweight Vision Transformers in diagnosis of pneumonia
AID  - 10.1101/2024.10.24.24316057
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.10.24.24316057
4099  - http://medrxiv.org/content/early/2024/10/24/2024.10.24.24316057.short
4100  - http://medrxiv.org/content/early/2024/10/24/2024.10.24.24316057.full
AB  - Pneumonia is one of the leading causes of death in children under five, particularly in resource-limited settings. The timely and accurate detection of pneumonia, often conducted through chest X-rays, remains a challenge due to the scarcity of trained professionals and the limitations of traditional diagnostic methods. In recent years, Artificial Intelligence (AI) models, especially Convolutional Neural Networks (CNNs), have been increasingly applied to automate pneumonia detection. However, CNN models are often computationally expensive and lack the ability to capture long-range dependencies in images, limiting their efficacy in certain medical applications. To address these limitations, lightweight hybrid models such as Vision Transformers (ViTs), which combine the strengths of CNNs and transformers, offer a promising solution. This study compares the efficacy of two lightweight CNNs (EfficientNet Lite0 and MobileNetV3 Large) with two hybrid ViTs (MobileViT Small and EfficientFormerV2 S0) for pneumonia detection. The models were evaluated on a publicly available chest X-ray dataset using metrics such as accuracy, F1 score, precision, and recall. Results show that the hybrid models, particularly MobileViT Small, outperformed their CNN counterparts in both accuracy (97.50%) and F1 score (0.9664), demonstrating the potential of ViT-based models for medical imaging tasks. The findings suggest that hybrid models provide superior recall, reducing false negatives, which is crucial for medical diagnostics. Further research should focus on optimizing these hybrid models to improve computational efficiency while maintaining high diagnostic performance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally located at: https://doi.org/10.17632/rscbjbr9sj.2I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript https://doi.org/10.17632/rscbjbr9sj.2